145 related articles for article (PubMed ID: 16362711)
1. Effect of preventive treatment on health-related quality of life in episodic migraine.
Bordini CA; Mariano da Silva H; Garbelini RP; Teixeira SO; Speciali JG
J Headache Pain; 2005 Oct; 6(5):387-91. PubMed ID: 16362711
[TBL] [Abstract][Full Text] [Related]
2. Quality of life assessment among migraine patients treated with sumatriptan.
Solomon GD; Skobieranda FG; Genzen JR
Headache; 1995 Sep; 35(8):449-54. PubMed ID: 7591736
[TBL] [Abstract][Full Text] [Related]
3. A 3-month analysis of disability, quality of life, and disease course in patients with migraine.
Raggi A; Leonardi M; Bussone G; D'Amico D
Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760
[TBL] [Abstract][Full Text] [Related]
4. Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire.
Dowson AJ; Tepper SJ; Baos V; Baudet F; D'Amico D; Kilminster S
Curr Med Res Opin; 2004 Jul; 20(7):1125-35. PubMed ID: 15265257
[TBL] [Abstract][Full Text] [Related]
5. The impact of migraine on daily activities: effect of topiramate compared with placebo.
Silberstein SD; Loder E; Forde G; Papadopoulos G; Fairclough D; Greenberg S
Curr Med Res Opin; 2006 Jun; 22(6):1021-9. PubMed ID: 16846536
[TBL] [Abstract][Full Text] [Related]
6. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
[TBL] [Abstract][Full Text] [Related]
7. The impact of topiramate on health-related quality of life indicators in chronic migraine.
Dodick DW; Silberstein S; Saper J; Freitag FG; Cady RK; Rapoport AM; Mathew NT; Hulihan J; Crivera C; Rupnow MF; Mao L; Finlayson G; Greenberg SJ
Headache; 2007; 47(10):1398-408. PubMed ID: 18052949
[TBL] [Abstract][Full Text] [Related]
8. Improvement in quality of life and activity limitations in migraine patients after prophylaxis. A prospective longitudinal multicentre study.
D'Amico D; Solari A; Usai S; Santoro P; Bernardoni P; Frediani F; De Marco R; Massetto N; Bussone G;
Cephalalgia; 2006 Jun; 26(6):691-6. PubMed ID: 16686908
[TBL] [Abstract][Full Text] [Related]
9. Evolution of the measurement of quality of life in migraine.
Solomon GD
Neurology; 1997 Mar; 48(3 Suppl 3):S10-5. PubMed ID: 9071264
[TBL] [Abstract][Full Text] [Related]
10. Changes in resource use and outcomes for patients with migraine treated with sumatriptan: a managed care perspective.
Lofland JH; Johnson NE; Batenhorst AS; Nash DB
Arch Intern Med; 1999 Apr; 159(8):857-63. PubMed ID: 10219932
[TBL] [Abstract][Full Text] [Related]
11. Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine.
Bagley CL; Rendas-Baum R; Maglinte GA; Yang M; Varon SF; Lee J; Kosinski M
Headache; 2012 Mar; 52(3):409-21. PubMed ID: 21929662
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
13. Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab.
Buse DC; Lipton RB; Hallström Y; Reuter U; Tepper SJ; Zhang F; Sapra S; Picard H; Mikol DD; Lenz RA
Cephalalgia; 2018 Sep; 38(10):1622-1631. PubMed ID: 30086681
[TBL] [Abstract][Full Text] [Related]
14. Low cognitive reserve is associated with chronic migraine with medication overuse and poor quality of life.
Gómez-Beldarrain M; Anton-Ladislao A; Aguirre-Larracoechea U; Oroz I; García-Moncó JC
Cephalalgia; 2015 Jul; 35(8):683-91. PubMed ID: 25304767
[TBL] [Abstract][Full Text] [Related]
15. Improvements in health-related quality of life with sumatriptan treatment for migraine.
Jhingran P; Cady RK; Rubino J; Miller D; Grice RB; Gutterman DL
J Fam Pract; 1996 Jan; 42(1):36-42. PubMed ID: 8537803
[TBL] [Abstract][Full Text] [Related]
16. Patient-reported quality of life after abdominal aortic aneurysm surgery: a prospective comparison of endovascular and open repair.
Aljabri B; Al Wahaibi K; Abner D; Mackenzie KS; Corriveau MM; Obrand DI; Meshefedjian G; Steinmetz OK
J Vasc Surg; 2006 Dec; 44(6):1182-1187. PubMed ID: 17145419
[TBL] [Abstract][Full Text] [Related]
17. Observational study of quality of life in patients with headache, receiving homeopathic treatment.
Muscari-Tomaioli G; Allegri F; Miali E; Pomposelli R; Tubia P; Targhetta A; Castellini M; Bellavite P
Br Homeopath J; 2001 Oct; 90(4):189-97. PubMed ID: 11680803
[TBL] [Abstract][Full Text] [Related]
18. Assessing the ability of topiramate to improve the daily activities of patients with migraine.
Brandes JL; Kudrow DB; Rothrock JF; Rupnow MF; Fairclough DL; Greenberg SJ
Mayo Clin Proc; 2006 Oct; 81(10):1311-9. PubMed ID: 17036556
[TBL] [Abstract][Full Text] [Related]
19. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
[TBL] [Abstract][Full Text] [Related]
20. Two center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implications.
Cady RK; Voirin J; Farmer K; Browning R; Beach ME; Tarrasch J
Headache; 2012 May; 52(5):749-64. PubMed ID: 22188311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
